facebook
twitter
rss
account
search
search
 

FDA rejects Byetta data

Nov. 6, 2008 at 12:04 AM   |   Comments

WASHINGTON, Nov. 6 (UPI) -- The U.S. Food and Drug Administration has rejected research data for a long-acting version of the diabetes drug Byetta.

The FDA rejected Eli Lilly's studies comparing small-scale batches of Byetta LAR made by partner Alkermes to large-scale batches made at an Amylin Pharmaceuticals manufacturing plant, Amylin said. Conducting a new study could delay the company's plans to seek approval next year, the Indianapolis Star reported.

The version of Byetta currently on the market is a twice-a-day injectable drug to help diabetics control their blood sugar, the newspaper said.

© 2008 United Press International, Inc. All Rights Reserved. Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI's prior written consent.
Most Popular
1
Android phones to join iPhone in saying no to the police Android phones to join iPhone in saying no to the police
2
Perth's first iPhone buyer immediately drops brand new phone on live TV Perth's first iPhone buyer immediately drops brand new phone on live TV
3
Major palm oil companies to halt deforestation Major palm oil companies to halt deforestation
4
Dogs are the favorite food of leopards in rural India Dogs are the favorite food of leopards in rural India
5
Tuna fishermen are not happy about proposed marine sanctuary Tuna fishermen are not happy about proposed marine sanctuary
Trending News
Video
x
Feedback